HIF1A and neoplasm: Furthermore, treatments with DDP and the HIF-1α inhibitor PX-478 in the human EC xenograft animal model confirmed that the tumor expression levels of the molecules in the lncRNA-EMS/miR-758-3p/WTAP axis were associated with tumor rejection efficiencies.